13D/13G Filings - RA Capital Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...23, 24, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-30
6:51 pm
Purchase
2024-12-2613DVor Biopharma Inc.
VOR
RA Capital Management, L.P.39,709,850
31.900%
16,929,507increase
(+74.32%)
Filing
History
2024-12-06
5:30 pm
Purchase
2024-11-2913GAlector, Inc.
ALEC
RA Capital Management, L.P.9,695,228
9.900%
9,695,228increase
(New Position)
Filing
History
2024-12-05
6:55 pm
Purchase
2024-11-2713GKura Oncology, Inc.
KURA
RA Capital Management, L.P.4,368,998
5.600%
4,368,998increase
(New Position)
Filing
History
2024-11-26
5:32 pm
Purchase
2024-11-2613DCidara Therapeutics, Inc.
CDTX
RA Capital Management, L.P.1,092,796
9.990%
389,716increase
(+55.43%)
Filing
History
2024-11-22
4:12 pm
Purchase
2024-11-1513GArcellx, Inc.
ACLX
RA Capital Management, L.P.2,787,327
5.200%
2,787,327increase
(New Position)
Filing
History
2024-11-18
8:19 pm
Unchanged
2024-11-1413D89bio, Inc.
ETNB
RA Capital Management, L.P.14,254,298
11.900%
0
(Unchanged)
Filing
History
2024-11-15
5:05 pm
Sale
2024-11-1313G4D Molecular Therapeutics, Inc.
FDMT
RA Capital Management, L.P.5,098,211
11.000%
-103,934decrease
(-2.00%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013G4D Molecular Therapeutics, Inc.
FDMT
RA Capital Management, L.P.5,202,145
9.990%
1,038,934increase
(+24.96%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GAstria Therapeutics, Inc.
ATXS
RA Capital Management, L.P.5,105,213
9.000%
692,063increase
(+15.68%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GNewAmsterdam Pharma Company N.V.
NAMS
RA Capital Management, L.P.9,095,589
9.990%
898,256increase
(+10.96%)
Filing
History
2024-11-14
5:46 pm
Sale
2024-09-3013GAscendis Pharma A/S
ASND
RA Capital Management, L.P.9,710,428
16.100%
-396,972decrease
(-3.93%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GGeron Corporation
GERN
RA Capital Management, L.P.63,319,553
9.990%
8,174,051increase
(+14.82%)
Filing
History
2024-11-14
5:46 pm
Sale
2024-09-3013GPraxis Precision Medicines, Inc.
PRAX
RA Capital Management, L.P.761,955
4.300%
-473,644decrease
(-38.33%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GRegulus Therapeutics Inc.
RGLS
RA Capital Management, L.P.766,834
1.200%
766,834increase
(New Position)
Filing
History
2024-11-14
5:46 pm
Unchanged
2024-09-3013GBicycle Therapeutics plc
BCYC
RA Capital Management, L.P.2,253,000
4.700%
0
(Unchanged)
Filing
History
2024-11-14
5:46 pm
Unchanged
2024-09-3013GCelcuity Inc.
CELC
RA Capital Management, L.P.1,286,960
3.400%
0
(Unchanged)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GDyne Therapeutics, Inc.
DYN
RA Capital Management, L.P.6,381,144
6.400%
1,167,483increase
(+22.39%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
RA Capital Management, L.P.21,539,465
9.990%
2,869,376increase
(+15.37%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GTenaya Therapeutics, Inc.
TNYA
RA Capital Management, L.P.7,980,736
9.990%
1,032,500increase
(+14.86%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GRxSight, Inc.
RXST
RA Capital Management, L.P.3,916,825
9.900%
512,540increase
(+15.06%)
Filing
History
Goto 0, 1, 2, ...23, 24, Next